USPTO serial 98001768
REMI
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- CANFIELD III, JOSEPH J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with REMI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEVEN JOHN HULTQUIST
STEVEN JOHN HULTQUIST HULTQUIST, PLLC510 MEADOWMONT VILLAGE CIRCLE, PMB #363CHAPEL HILL, NC 27517UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | antibiotic pharmaceuticals, anti-diabetic pharmaceuticals, antiviral pharmaceuticals, ocular pharmaceuticals, cardiovascular pharmaceuticals, pulmonary pharmaceuticals, bronchodilator pharmaceuticals, analgesic pharmaceuticals, muscle relaxant pharmaceuticals, hyperlipidemia pharmaceuticals, psychotropic pharmaceuticals, decongestant pharmaceuticals, weight loss pharmaceuticals, anticancer pharmaceuticals, antidepressant pharmaceuticals, vaccine pharmaceuticals, antihelmintic pharmaceuticals, antitussive pharmaceuticals, and anticoagulant pharmaceuticals; prescription medicines, namely, prescription pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases and for the treatment of diabetes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders | ACTIVE | — |
| 044 | telemedicine services; telehealth services in the nature of telemedicine services; medical information services; medical information services provided via the Internet; providing medical information; prescription medicine refill reminder services; online pharmaceutical medication counseling and prescription services in the nature of preparation of prescriptions by pharmacists | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celmatrix Corporation
- Other trademarks owned by REMI INVESTMENT HOLDINGS, LLC
- Other trademarks owned by REMI INVESTMENT HOLDINGS, LLC
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named REMI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 27, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 27, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 31, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 4, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 16, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 10, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 10, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 10, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |